MANA RBM - Risk-Based Monitoring

MANA RBM - Risk-Based Monitoring Leaders in Clinical Research Innovation MANA RBM is your expert source for implementing Monitoring for Clinical Research.

Risk-Based Monitoring is the recommended approach for quality oversight for all clinical trials using Investigational Products (medicines, vaccines, and devices). The approach is based in the principles of Quality by Design and is recommended by the Food and Drug Administration (FDA), European Medicines Agency (EMA), and the International Council on Harmonization (ICH). MANA RBM supports design of

processes, technology and training for staff on the new methods required for Risk-Based Monitoring. Alternative options from MANA RBM include MANA and partners functioning as a Clinical Research Organization or providing a Knowledge Transfer to your organization.

Address

1401 Wewatta Street
Denver, CO
80202

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

(919) 556-9456

Website

Alerts

Be the first to know and let us send you an email when MANA RBM - Risk-Based Monitoring posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MANA RBM - Risk-Based Monitoring:

Shortcuts

Share

Category